Royal Society of Chemistry, Journal of Materials Chemistry B: Materials for biology and medicine, 9(7), p. 1503-1509, 2019
DOI: 10.1039/c8tb03188f
Full text: Unavailable
A nanomized NIR fluorescent prodrug was developed with improved bioavailability and tumor-targeting ability. Nanomized tumor-microenvironment-active NIR DCM-S-GEM/PEG prodrug provides a novel approach to realize long real-time tracking of drug delivery and activation process without systemic toxicity in vivo.